CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,199,950 | -9.7% | 2,654,445 | 0.0% | 0.58% | +32.7% |
| Q2 2023 | $86,587,996 | -5.8% | 2,654,445 | +1.6% | 0.44% | -26.8% |
| Q1 2023 | $91,905,441 | -26.4% | 2,611,692 | -4.2% | 0.60% | -40.0% |
| Q4 2022 | $124,849,282 | -3.5% | 2,724,777 | +2.0% | 1.00% | +20.6% |
| Q3 2022 | $129,441,000 | +8.8% | 2,671,648 | -11.7% | 0.82% | +18.2% |
| Q2 2022 | $118,917,000 | +1.5% | 3,026,648 | -4.9% | 0.70% | +32.2% |
| Q1 2022 | $117,104,000 | -30.0% | 3,181,300 | -13.4% | 0.53% | -15.9% |
| Q4 2021 | $167,368,000 | +55.3% | 3,671,969 | +21.8% | 0.63% | +42.7% |
| Q3 2021 | $107,752,000 | +124.1% | 3,014,882 | +24.1% | 0.44% | +110.5% |
| Q2 2021 | $48,072,000 | -22.6% | 2,429,100 | -9.1% | 0.21% | -45.7% |
| Q1 2021 | $62,148,000 | -8.6% | 2,671,884 | -18.3% | 0.38% | -6.6% |
| Q4 2020 | $67,990,000 | – | 3,271,884 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |